Datar Cancer Genetics Private Limited

Datar Cancer Genetics Private Limited - healthcare in Nashik, Maharashtra, India. FY 2026 financials & compliance.
CIN U01110MH1992PTC067409 Incorporated 24 June 1992 ROC Mumbai HQ Nashik, Maharashtra, India
Active Private Limited Company healthcare MSME · Medium
Data last updated
Revenue · FY 2025
₹102.27 Cr
▲ 31% YoY
Net loss · FY 2025
₹3.85 Cr
Net margin -3.8%
EBITDA · FY 2025
₹21.6 Cr
EBITDA margin 21.1%
Authorised capital
₹125.8 Cr
Registered with MCA
Paid-up capital
₹120.41 Cr
Issued & subscribed
Open charges
₹18.14 Cr
Satisfied ₹1.38 Cr
Company age
34 yrs
Est. 1992
Directors on board
3
As per MCA filings

About Datar Cancer Genetics Private Limited

Data last updated:

Datar Cancer Genetics Private Limited is a private limited company based in Nashik, Maharashtra, India. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 24 June 1992 and has been in existence for over 34 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U01110MH1992PTC067409. Its GSTIN is 27AAECD6148D1ZS (Maharashtra).

The company has an authorised share capital of ₹125.8 Cr and a paid-up capital of ₹120.41 Cr. It was formerly known as Datar Agro Plantations Limited and Datar Cancer Genetics Limited. It is led by directors including Sneha Rajan Datar and Swati Satish Deshpande.

Its last annual general meeting (AGM) was held on 15 July 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at F – 8 D – Road Ambad, Nashik, Maharashtra, India – 422010.

As per the financials filed for FY 2025, the company reported a revenue of ₹102.27 Cr, a growth of 31% compared to the previous year. For the same year it recorded a net loss of ₹3.85 Cr (net margin -3.8%) and EBITDA of ₹21.6 Cr (EBITDA margin 21.1%). Revenue has grown at a compounded annual rate (CAGR) of 16% over three years and 51% over five years.

Its group structure includes 1 subsidiary.

The company is associated with 2 brands: EasyCheck360 and Datar Genetics. As per MCA filings, the company has open charges of ₹18.14 Cr and satisfied charges of ₹1.38 Cr on record. Court records list 8 cases involving the company, including 5 filed by the company and 3 filed against it; 2 cases are pending. The company has 15 deals on record (9 secondary share transfers, 4 funding rounds, 2 rights issues), with disclosed funding of ₹7.1 Cr; the latest was in March 2022. Its 4 peer companies in the Healthcare industry (Diagnostics and Pathology Labs), with the same principal business activity (other hospital and medical care activities) are compared by revenue, 1 larger and 3 smaller; the largest is GHL Pharma & Diagnostic Private Limited with revenue of ₹106.96 Cr.

Datar Cancer Genetics Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-23-0085020). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website datarpgx.com.

Company details

CIN U01110MH1992PTC067409
Registration Number 067409
Incorporation Date 24 June 1992
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 15 July 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MH-23-0085020

Name history

Datar Cancer Genetics has undergone 3 name changes throughout its history. The company was previously known as Datar Agro Plantations Limited, Datar Cancer Genetics Limited, and Datar Genetics Limited. The current legal name is Datar Cancer Genetics Private Limited.

Company NameStatus
Datar Cancer Genetics Private LimitedCurrent
Datar Agro Plantations LimitedPrevious
Datar Cancer Genetics LimitedPrevious
Datar Genetics LimitedPrevious

CIN history

Datar Cancer Genetics has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U01110MH1992PTC067409, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U01110MH1992PTC067409Current
U01100MH1992PTC067409Previous
U01110MH1992PLC067409Previous
Key People
Sneha Rajan Datar Director Swati Satish Deshpande Director Rajan Bhalchandra Datar Director

Recognitions & Rankings of Datar Cancer Genetics

MSME (Udyam registered) Ministry of MSME
Category
Medium (2024-25)
Udyam number
UDYAM-MH-23-0085020

Contact details

Datar Cancer Genetics Private Limited's registered office is in Nashik, Maharashtra. Its website is datarpgx.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    datarpgx.com
  • Social Media
  • Registered Address
    F – 8 D – Road Ambad, Nashik, Maharashtra, India – 422010
  • Industry
    Healthcare, Diagnostic Centers & Pathology Labs

To see the full contact details of Datar Cancer Genetics Private Limited, buy the company report.

Comprehensive company report
Datar Cancer Genetics Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Datar Cancer Genetics operates two associated brands: EasyCheck360 and Datar Genetics. Each brand links to its own profile.

BrandDescriptionWebsite
EasyCheck360
Provides blood tests for early cancer screening, diagnosis, and treatment monitoring.easycheck360.com
Datar Genetics
Liquid biopsy-based cancer diagnostic tests are provided.datarpgx.com

Business activity

The main business activity of Datar Cancer Genetics is hospital and medical care. In detail, this covers other hospital and medical care activities.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
QHospital and Medical CareQ6Other Hospital and Medical Care Activities

To see the full business activity and turnover split of Datar Cancer Genetics Private Limited, buy the company report.

Financials of Datar Cancer Genetics Private Limited

FY 2024 filings available

Datar Cancer Genetics Private Limited reported revenue of ₹102.27 Cr (up 31% YoY) for FY 2025.

Revenue · FY 2025
₹102.27 Cr ▲ 31%
Net loss · FY 2025
₹3.85 Cr margin -3.8%
EBITDA · FY 2025
₹21.6 Cr margin 21.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 31%
3 years · compounded
▲ 16%
5 years · compounded
▲ 51%
EBITDA CAGR growth
1 year
▲ 6%
3 years · compounded
▲ 37%
5 years · compounded
▲ 27%

Revenue has grown at a compounded annual rate (CAGR) of 51% over five years, including 31% growth in the latest year. EBITDA rose 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹21.6 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹3.85 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin21.1%
Net Profit Margin-3.8%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Datar Cancer Genetics Private Limited, buy the company report.

Board of directors of Datar Cancer Genetics Private Limited

Datar Cancer Genetics has 3 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Sneha Rajan Datar
Also directs: Datar Power Management Private Limited, Sungrace Electricals Pvt Ltd, Blue Leopard Genomic Essentials Private Limited and 2 more
Director01 Apr 201313 Years 7 MonthsCurrent
Swati Satish Deshpande
Also directs: Sungrace Electricals Pvt Ltd, Blue Leopard Genomic Essentials Private Limited
Director23 Oct 20206 Years 0 MonthsCurrent
Rajan Bhalchandra Datar
Also directs: Datar Cancer Foundation, Ridge Innovations Private Limited, Liquid Biopsy Research Foundation of India
Director25 Mar 20224 Years 7 MonthsCurrent
View all directors

Peer comparison

Datar Cancer Genetics Private Limited is compared with the 4 companies closest to it by revenue in the Healthcare industry (Diagnostics and Pathology Labs), with the same principal business activity (other hospital and medical care activities), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
GHL Pharma & Diagnostic Private Limited₹106.96 Cr (FY 2025)392.0%Delhi, India
Datar Cancer Genetics Private Limitedthis company₹102.27 Cr (FY 2025)-₹3.85 Cr-3.8%31.0%Nashik, Maharashtra, India
Lupin Diagnostics Limited₹98.57 Cr (FY 2025)42.0%Mumbai, Maharashtra, India
Oncquest Laboratories Limited₹97.99 Cr (FY 2025)0.0%New Delhi, Delhi, India
Accuprobe Healthcare and Diagnostics Private Limited₹94.78 Cr (FY 2025)35.0%Delhi, India

To see the full peer comparison of Datar Cancer Genetics Private Limited, buy the company report.

Auditor

Datar Cancer Genetics Private Limited is audited by M/S YOGESH PUNDE AND ASSOCIATES for the financial year 2023.

Auditor firmFinancial yearFirm registration number
M/S YOGESH PUNDE AND ASSOCIATESFY 2023126339W

Shareholding

The shareholding of Datar Cancer Genetics Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Datar Cancer Genetics Private Limited, buy the company report.

Charges & borrowings

Open charges
₹18.14 Cr
Satisfied charges
₹1.38 Cr
Breakdown by lending institutions
Others₹18.14 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
18 Oct 2025101186462Others₹18.14 CrOpen
16 Jan 2023100674091Hdfc Bank Limited₹92.85 LakhSatisfied
20 Dec 2022100665917Hdfc Bank Limited₹45.25 LakhSatisfied

To see the full charge records of Datar Cancer Genetics Private Limited, buy the company report.

Total charge records: 3 View all charges

Deals & funding

Datar Cancer Genetics Private Limited has 15 deals on record (9 secondary share transfers, 4 funding rounds, 2 rights issues), with disclosed funding of ₹7.1 Cr; the latest was in March 2022.

Total deals
15
Secondary share transfers
9
Funding rounds
4
Rights issues
2
Disclosed funding
₹7.1 Cr

Deals on record (5 of 15)

WhenDealAmountParties
Mar 2022Secondary share transferUndisclosedBuyer: an individual
Seller: Blue Leopard Private Limted, an individual
Feb 2022Rights issue₹100.5 CrInvestors: an individual
Nov 2021Secondary share transferUndisclosedBuyer: 4 individuals
Seller: Blue Leopard Private Limted
Oct 2021Secondary share transferUndisclosedBuyer: 4 individuals
Seller: Blue Leopard Private Limted
Apr 2016Secondary share transferUndisclosedBuyer: Medintel Services Private Limited , 3 individuals
Seller: an individual

To see the full deal history of Datar Cancer Genetics Private Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Datar Cancer Genetics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Group structure & subsidiaries

Datar Cancer Genetics has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.

1
Subsidiary companies
Key subsidiaries
Company NameCINShares held
Blue Leopard Genomic Essentials Private LimitedlimitedU73100MH2017PTC298233

To see the full group structure of Datar Cancer Genetics Private Limited, buy the company report.

GST

Datar Cancer Genetics has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AAECD6148D1ZSMaharashtraActive12 Oct 2020

To see the full GST registrations and return filing status of Datar Cancer Genetics Private Limited, buy the company report.

Recent activity

Datar Cancer Genetics Private Limited has 8 board changes on record since 2013: 4 appointments and 4 cessations. The latest: Aditi Sanjit Bagul was appointed as Company Secretary on 12 Oct 2022.

Charges
A charge with Others amounted to Rs. 18.14 Cr with Charge ID 101186462 was registered on 18 Oct 2025.
Charges
A charge registered on 16 Jan 2023 via Charge ID 100674091 with Hdfc Bank Limited was fully satisfied on 16 Jul 2024.
Charges
A charge registered on 20 Dec 2022 via Charge ID 100665917 with Hdfc Bank Limited was fully satisfied on 16 Jul 2024.
AGM
Datar Cancer Genetics Private Limited last Annual general meeting of members was held on 15 Jul 2024 as per latest MCA records.
Filing
Datar Cancer Genetics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.93 Cr with Charge ID 100674091 was registered on 16 Jan 2023.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.45 Cr with Charge ID 100665917 was registered on 20 Dec 2022.
Appointed
Aditi Sanjit Bagul was appointed as Company Secretary.
Appointed
Rajan Bhalchandra Datar was appointed as Director.
Ceased
Dayanand Sunil Sahane ceased to be Company Secretary.
Ceased
Rajan Bhalchandra Datar ceased to be Managing Director.
Ceased
Shobhana Rajan Datar ceased to be Director.

4 earlier events are in the company report.

News

Frequently asked questions

Datar Cancer Genetics is an active private limited company based in Nashik, Maharashtra, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 24 June 1992 (34+ years old) and is registered under CIN U01110MH1992PTC067409.

Datar Cancer Genetics has 3 current directors:

The latest financial statements of Datar Cancer Genetics on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 15 July 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Datar Cancer Genetics is 27AAECD6148D1ZS, registered in Maharashtra.

The CIN (Corporate Identification Number) of Datar Cancer Genetics is U01110MH1992PTC067409. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Datar Cancer Genetics has 8 court cases on record: 5 filed by the company and 3 filed against it. 2 are pending. Most are in the high courts.

Datar Cancer Genetics was incorporated on 24 June 1992, making it 34+ years old. It is registered with the Registrar of Companies, Mumbai.

Datar Cancer Genetics has 15 deals on record (9 secondary share transfers, 4 funding rounds, 2 rights issues), with disclosed funding of ₹7.1 Cr; the latest was in March 2022.

The peers of Datar Cancer Genetics by revenue are GHL Pharma & Diagnostic Private Limited, Lupin Diagnostics Limited, Oncquest Laboratories Limited, Accuprobe Healthcare and Diagnostics Private Limited, all in the Healthcare industry (Diagnostics and Pathology Labs), with the same principal business activity (other hospital and medical care activities).

Aditi Sanjit Bagul was appointed as Company Secretary on 12 Oct 2022. Rajan Bhalchandra Datar was appointed as Director on 25 Mar 2022. Dayanand Sunil Sahane ceased to be Company Secretary on 04 Nov 2020. Datar Cancer Genetics has 8 board changes on record in total.

Yes, Datar Cancer Genetics is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-23-0085020).